TYBR Health, Inc.

TYBR Health is a Houston-based medtech company founded in 2020, specializing in regenerative medicine and post-operative recovery solutions for orthopedic surgery. The company addresses a critical clinical gap: while surgical procedures for tendon and ligament repair are often technically successful, post-surgical tissue scarring and adhesions frequently result in long-term functional limitations and mobility restrictions affecting patient outcomes. TYBR Health's flagship product, B3 GEL™, is a naturally derived, flowable bio-gel barrier designed to be applied intraoperatively to coat tendons, ligaments, and surrounding tissues during minimally invasive procedures. The hydrogel creates a protective barrier that mitigates internal scarring and tissue tethering, supporting optimal healing and functional recovery. The solution targets the approximately 120,000 annual tendon procedures performed in the United States, where up to 40% of patients currently face lifelong mobility limitations despite surgical success.